AJIBOLA BABATUNDE: Open Payments
NPI 1629573936 · ACWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 12 payments from 9 companies in 2025. Trend: 2023 $19 · 2024 $0 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| DePuy Synthes Sales Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $104 |
| Braeburn Inc. | 3 | $82 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $23 |
| Virtus Pharmaceuticals LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: TRUMATCH, BRIXADI, XTAMPZA, AUSTEDO XR, VIVITROL, LEVORPHANOL TARTRATE, RELISTOR, MOUNJARO.
Industry payments across GA — which companies pay providers there.
